Drawing for REGENPRP

USPTO serial 86760906

REGENPRP

Reviewed by CopyMark Law Group

Status 807Office Action
Filing date
Status date
Registration date
—
Examiner
RILEY, KATHERINE M
Law office
TMO LAW OFFICE 117

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Need help with REGENPRP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lindsay Kaplan

P.O. Box 4062Kingston, NY 12402United States

Goods and services

ClassDescriptionStatusFirst use
041educational services, namely, design, organization and conducting colloquia, seminars, symposia, educational conferences, educational conventions, and discussion fora in real time, over Internet-type networks or Intranet-type networks, and other events for educational purposes in the field of tissue and cellular enhancement, repair, reconstruction, regeneration and rejuvenation, regenerative medicine; Educational services, namely, design, organization and conducting colloquia, seminars, symposia, educational conferences, educational conventions, and discussion fora in real time, over Internet-type networks or Intranet-type networks, and other events for educational purposes in the field of blood or bone marrow related components including platelets, plasma concentrates, thrombin serum and stem cells, hyaluronic acid, chitosan or silk, to mesotherapy, to the isolation, application, micro-needling and/or injection of a patient's own platelets, thrombin serum and/or cells alone or in combination with any other substance including cell extract or cell extracts, stem cells, hyaluronic acid, chitosan or silkACTIVEAug 31, 2024
042research services, namely, scientific research studies in the field of tissue and cellular enhancement, repair, reconstruction, regeneration and rejuvenation, regenerative medicine; research services, namely, scientific research studies in the field of blood or bone marrow related components including platelets, plasma concentrates, thrombin serum and stem cells, to hyaluronic acid, chitosan or silk, to mesotherapy, to the isolation, application, micro-needling and/or injection of a patient's own platelets, thrombin serum and/or cells alone or in combination with any other substance including cell extract or cell extracts, stem cells, hyaluronic acid, chitosan or silk; research services, namely, scientific research studies in the field of platelet rich plasma, platelet poor plasma, platelet rich fibrin, blood platelet concentrate, platelet fibrin gel, white blood cells, buffy coat, stem cells, and other blood related extracts or any combination of blood contentsACTIVEAug 31, 2024
044medical, cosmetic and beauty services, namely, treatments using platelet rich plasma, platelet poor plasma, platelet rich fibrin, blood platelet concentrate, platelet fibrin gel, white blood cells, buffy coat, stem cells, and other blood related extracts or any combination of blood contents in the field of tissue and cellular enhancement, repair, reconstruction, regeneration and rejuvenation, regenerative medicine; medical, cosmetic and beauty services, namely, treatments using platelet rich plasma, platelet poor plasma, platelet rich fibrin, blood platelet concentrate, platelet fibrin gel, white blood cells, buffy coat, stem cells, and other blood related extracts or any combination of blood contents in the field of blood or bone marrow related components including platelets, plasma concentrates, thrombin serum and stem cells, to mesotherapy, to hyaluronic acid, chitosan or silk, to the isolation, application, micro-needling and/or injection of a patient's own platelets, thrombin serum and/or cells alone or in combination with any other substance including cell extract or cell extracts, stem cells, hyaluronic acid, chitosan or silkACTIVEAug 31, 2024

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (GNRN): A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

DateCodeEventWhat it means
Aug 25, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 25, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 25, 2026CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 21, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jul 20, 2026IUAFUSE AMENDMENT FILED—
Jul 20, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jan 23, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 22, 2026EX5GSOU EXTENSION 5 GRANTED—
Jan 20, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 19, 2026EXT5SOU EXTENSION 5 FILED—
Aug 8, 2025DPCCDIVISIONAL PROCESSING COMPLETE—
Aug 1, 2025DRRRDIVISIONAL REQUEST RECEIVED—
Aug 1, 2025ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Aug 1, 2025EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jul 18, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 17, 2025EX4GSOU EXTENSION 4 GRANTED—
Jul 17, 2025EXT4SOU EXTENSION 4 FILED—
Jul 17, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 22, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 22, 2025EX3GSOU EXTENSION 3 GRANTED—
Jan 21, 2025EXT3SOU EXTENSION 3 FILED—
Jan 21, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 5, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 5, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 5, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 24, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 18, 2024EX2GSOU EXTENSION 2 GRANTED—
Jul 18, 2024EXT2SOU EXTENSION 2 FILED—
Jul 18, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 15, 2024EX1GSOU EXTENSION 1 GRANTED—
Jun 14, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 10, 2024AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 29, 2024DOCKASSIGNED TO EXAMINER—
Feb 20, 2024NREVNOTICE OF REVIVAL - E-MAILED—
Feb 20, 2024PETGPETITION TO REVIVE-GRANTED—
Feb 20, 2024PROATEAS PETITION TO REVIVE RECEIVED—
Feb 19, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 18, 2024EXT1SOU EXTENSION 1 FILED—
Jul 18, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 23, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 23, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 3, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 17, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 27, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 27, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 27, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 17, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 17, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 17, 2023ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Feb 21, 2023DOCKASSIGNED TO EXAMINER—
Dec 20, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 20, 2022EWORTEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED—
Dec 20, 2022EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Dec 20, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 20, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 19, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Dec 19, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 19, 2022EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Dec 19, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 19, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 19, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 19, 2022GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Dec 19, 2022GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 19, 2022CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 17, 2022RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Mar 21, 2022RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Sep 20, 2021RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Feb 22, 2021RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Aug 20, 2020RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jan 27, 2020RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jul 24, 2019RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Feb 21, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 21, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 24, 2019RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Oct 1, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 1, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 24, 2018RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jan 24, 2018RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jul 24, 2017RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jul 5, 2017ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jan 14, 2017RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jul 14, 2016GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jul 14, 2016GNSLLETTER OF SUSPENSION E-MAILED—
Jul 14, 2016CNSLSUSPENSION LETTER WRITTEN—
Jun 24, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 24, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 24, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 2, 2016ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 2, 2016REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 9, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 9, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 9, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 6, 2016DOCKASSIGNED TO EXAMINER—
Sep 22, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 22, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance